| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.06B | 17.01B | 15.64B | 30.87B | 10.34B | 13.26B |
| Gross Profit | 20.06B | 14.45B | 15.64B | 23.17B | 2.28B | 7.07B |
| EBITDA | -142.00M | -870.00M | 549.00M | -3.85B | -168.00M | 1.52B |
| Net Income | -620.00M | -1.09B | 56.00M | -2.72B | -837.00M | 798.00M |
Balance Sheet | ||||||
| Total Assets | 309.97B | 307.86B | 299.31B | 281.04B | 327.77B | 334.32B |
| Cash, Cash Equivalents and Short-Term Investments | 9.98B | 9.45B | 7.22B | 8.84B | 9.11B | 11.00B |
| Total Debt | 3.47B | 4.23B | 3.88B | 4.65B | 4.82B | 5.14B |
| Total Liabilities | 308.18B | 305.61B | 295.77B | 276.80B | 318.94B | 326.45B |
| Stockholders Equity | 1.26B | 1.71B | 2.99B | 3.71B | 5.82B | 7.53B |
Cash Flow | ||||||
| Free Cash Flow | 1.33B | 3.34B | -863.00M | 866.00M | -1.26B | 6.58B |
| Operating Cash Flow | 1.34B | 3.37B | -863.00M | 866.00M | -1.26B | 6.58B |
| Investing Cash Flow | -44.00M | -29.00M | -20.00M | 0.00 | 304.00M | -988.00M |
| Financing Cash Flow | -787.00M | -1.08B | -769.00M | -1.18B | -857.00M | 942.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £7.04B | -9.81 | -41.76% | 7.48% | -34.62% | -19.20% | |
66 Neutral | £27.87B | 9.78 | 26.87% | 1.56% | 37.94% | 291.37% | |
61 Neutral | £6.46B | 13.86 | 37.33% | 1.06% | -36.55% | ― | |
53 Neutral | £674.37M | -59.40 | -2.93% | 8.03% | -48.03% | -289.17% | |
52 Neutral | £6.93B | 22.80 | 9.49% | 7.09% | 9.86% | -134.41% | |
48 Neutral | £14.55B | 30.04 | 15.89% | 8.29% | -38.98% | -31.14% |